Life Science Matters An inside look at the latest legal developments involving medical devices, pharmaceuticals, and more

  • Home
  • About
  • Categories
    • ANDA
    • Class Action
    • Coronavirus
    • Daubert
    • Design Defect
    • FDA
    • IP
    • Labeling
    • Medical Device
    • News
    • Nutritional Supplements
    • Off Label
    • Pharmacy
    • Pharmaceuticals
    • Preemption
    • Recalls
    • Regulatory
    • Sales Representatives
    • Settlements
    • Supplements
    • Verdicts
  • Resources
  • Subscribe
  • Contact Us

This Week’s Life Science Headlines

  • November 15, 2013
  • /
  • Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Preemption Recalls Regulatory Settlements Supplements
  • /
  • Life Science Matters
        Litigation
  • Eli Lilly, Others Urge 6th Circ. To Toss Darvocet Appeal (subscription required)
  • McNeil Asks Pa. Appeals Court to Boot $10M Motrin Verdict (subscription required)
  • J&J to Pay $4B to Settle Hip Implant Suits (subscription required)
  • J&J Trying to Back Out of 77 Risperdal Deals, Plaintiffs Say (subscription required)
  • Birth Defect Lawyers in Effexor MDL Assigned to Leadership Roles
  • Final Bard Avaulta Vaginal Mesh Bellweather Trial Set for Dec. 3
  • Stryker Rejuvenate Hip Attorneys Assigned to leadership Positions in MDL
…
Continue reading...
  • aegerion AstraZeneca Atossa avaulta Bard Baylis brilinta crestor darvocet DMAA drug promo claims effexor effexor birth defect effexor MDL Eli Lilly generic labeling generic preemption hip implant hip implant suits Janssen Johnson and Johnson juxtapid Lipitor MASCT McNeil Motrin Verdict new guidelines OxyElite OxyElite Pro Dietary Supplement pradaxa pradaxa litigation risperdal risperdal settlement Smokers' Medical Monitoring Claims statins stryker stryker hip implant surgical robots TorFlex vaginal mesh whistleblower
Goldberg Segalla

Search

Categories

  • Posts
  • Multicounty Litigation Order in New Jersey Provides No Guidance to Practitioners June 23, 2021
  • New Multicounty Litigation Application in New Jersey June 8, 2021
  • Lack of Agreement to Arbitrate Dooms Bid to Compel Arbitration May 26, 2021
  • Mixed Bag in New Jersey Medical Device Preemption Opinion May 12, 2021
  • First Circuit Agrees Pharmacists Provide Services, Not Sell Goods April 27, 2021

About Us

Goldberg Segalla is a national civil litigation firm with more than 20 offices in 10 states spanning major metro markets across the U.S., providing strategic coverage wherever our clients do business. As a firm of experienced litigators and trial attorneys, our capabilities span business and commercial disputes, employment and labor, insurance coverage, product liability, and more. Today, our nearly 400 attorneys are trusted counselors to public and private clients in key sectors and industries including construction and energy, transportation, manufacturing, retail and hospitality, and insurance.

Links

  • Home
  • About
  • Resources
  • Contact Us
Copyright 2023 ยท Goldberg Segalla